Sodium Nitroprusside

CHEMBL136478 Phase 4 Approuvé Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

261.9 g/mol

LogP

—

Phase

4

Administered through an intravenous drip in critical care settings, this potent vasodilator instantly relaxes blood vessel walls to bring down dangerously high blood pressure or reduce the workload on a failing heart. Its effects begin within seconds and stop almost immediately when the infusion is slowed, allowing precise minute-by-minute blood pressure control.

Masse moléculaire

261,9200 g/mol

TPSA

144,00 Å²

Aires thérapeutiques

Ovarian Cancer Pancreatic Cancer Bladder Cancer Thyroid Cancer Glaucoma Cardiovascular Disease Non-Small Cell Lung Cancer Chronic Obstructive Pulmonary Disease Schizophrenia Chronic Kidney Disease Stroke Hyperlipidemia Obesity Lymphoma Type 2 Diabetes Hypertension Breast Cancer Heart Failure Atrial Fibrillation Prostate Cancer Colorectal Cancer Leukemia

Pharmacokinetics (PK)

Pharmacodynamics (PD)

SMILES

[C-]#N.[C-]#N.[C-]#N.[C-]#N.[C-]#N.N#[O+].[Na+].[Na+].[Fe+2]

InChI

InChI=1S/5CN.Fe.NO.2Na/c5*1-2;;1-2;;/q5*-1;+2;3*+1

Molecular Formula

C5FeN6Na2O

HBD / HBA

- / 11

Liaisons Rotatives

0

Atomes Lourds

15

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Foire aux questions

Administered through an intravenous drip in critical care settings, this potent vasodilator instantly relaxes blood vessel walls to bring down dangerously high blood pressure or reduce the workload on a failing heart. Its effects begin within seconds and stop almost immediately when the infusion is slowed, allowing precise minute-by-minute blood pressure control.

Yes, Sodium Nitroprusside is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL136478. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 6604165. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Vous cherchez des informations accessibles aux patients ?

Sodium Nitroprusside sur PillFYI

Données Clés

Formule: C5FeN6Na2O
Synonymes: 1

Liens externes

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Avertissement médical

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.